Bvh-a2 and bvh-a3 antigens of group b streptococcus

a technology of streptococcus and antigens, which is applied in the field of polypeptides of group b streptococcus, can solve the problems of postpartum infection, death, disability, and recurrence of infection of expectant mothers exposed to gbs

Inactive Publication Date: 2008-09-18
ID BIOMEDICAL
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The immunogenic polypeptides elicit a protective immune response, potentially reducing the incidence and severity of GBS infections by providing significant antibody binding specificity and increased survival rates.

Problems solved by technology

Expectant mothers exposed to GBS are at risk of postpartum infection and may transfer the infection to their baby as the child passes through the birth canal.
In addition to acute illness due to GBS, which is itself costly, GBS infections in newborns can result in death, disability, and, in rare instances, recurrence of infection.
Although the organism is sensitive to antibiotics, the high attack rate and rapid onset of sepsis in neonates and meningitis in infants results in high morbidity and mortality.
Unfortunately these polysaccharides have proven to be poorly immunogenic in hosts and are restricted to the particular serotype from which the polysaccharide originates.
Consequently capsular polysaccharide antigens are unsuitable as a vaccine component for protection against GBS infection.
This protein was found to be unsuitable as a human vaccine because of its undesirable property of interacting with high affinity and in a non-immunogenic manner with the Fc region of human IgA.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Bvh-a2 and bvh-a3 antigens of group b streptococcus
  • Bvh-a2 and bvh-a3 antigens of group b streptococcus
  • Bvh-a2 and bvh-a3 antigens of group b streptococcus

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0153]This example illustrates the identification of GBS BVH-A2 and BVH-A3 genes.

[0154]Chromosomal DNA was isolated from different GBS strains as previously described (Jayarao B M et al. 1991. J. Clin. Microbiol.29: 2774-2778). A λZAPExpress genomic library was constructed using chromosomal DNA purified from the serotype III GBS strain NCS954 and screened according to the manufacturer's instruction (STRATAGENE, La Jolla, Calif.) with a pool of human normal sera. Briefly, the purified chromosomal DNA was partially digested with tsp509I restriction enzyme, and the resulting fragments were electrophoresed on a 1% agarose gel (Bio-Rad). Fragments in the 5-to 10-kb size range were extracted from the gel and ligated to the EcoRI arms of λZAPExpress vector and the vector was encapsidated using the Gigapack II packaging extract (STRATAGENE). The recombinant phages were used to infect E. coli XLI-Blue MRF′ [Δ(mcrA)183Δ(mcrCB-hsdSMR-mrr)173 endAl supE44 thi-1 recA1 gyrA96 relAl lac (F′ proAB ...

example 2

[0155]This example illustrates the cloning of GBS BVH-A2 and BVH-A3 genes.

[0156]The coding regions of Group B streptococcal BVH-A2 (SEQ ID NO: 1) and BVH-A3 (SEQ ID NO: 5) genes were respectively amplified by PCR (DNA Thermal Cycler GeneAmp PCR system 2400 Perkin Elmer, San Jose, Calif.) from purified recombinant phagemid clone H31-29 and genomic DNA of serotype III Group B streptococcal strain NCS954 using oligonucleotide primers that contained base extensions for the addition of restriction sites Ndel (CATATG) and Xhol (CTCGAG). The oligonucleotide primers (Table 1) DMAR172 (SEQ ID NO:9) and DMAR173 (SEQ ID NO:10) were used to amplify the BVH-A2 gene, while DMAR204 (SEQ ID NO:15) and DMAR205 (SEQ ID NO:16) were used to amplify the BVH-A3 gene. PCR products were purified from agarose gel using a QIAQUICK gel extraction kit from QIAGEN following the manufacturer's instructions (Chatsworth, Calif.), and digested with Ndel and Xhol (Pharmacia Canada Inc, Baie d'Urfé, Canada). The pET-...

example 3

[0159]This example describes the PCR amplification of GBS BVH-A2 and BVH-A3 genes from other GBS strains

[0160]To confirm the presence by PCR amplification of BVH-A2 (SEQ ID NO:1) and BVH-A3 (SEQ ID NO:5) genes, the following 11 serologically distinct GBS strains were used: C388 / 90 (serotype Ia / c), ATCC12401 (serotype Ib), ATCC27591 (serotype Ic), NCS246 (serotype II / R), NCS954 (serotype III), NCS97SR331 (serotype IV), NCS535 (serotype V), NCS9842 (serotype VI), NCS7271 (serotype VII), NCS970886 (serotype VIII), ATCC27956 (bovine isolate). These strains were obtained from the American Type Culture Collection (Rockville, Md., USA) and National Centre for Streptococcus, Provincial Laboratory of Public Health for Northern Alberta (Edmonton, Canada). The E. coli strain XL1-Blue MRF′ was used in these experiments as negative control. Chromosomal DNA was isolated from each Group B streptococcal strain as previously described (Jayarao B M et al. 1991. J. Clin. Microbiol. 29:2774-2778). BVH-...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightsaaaaaaaaaa
molecular weightsaaaaaaaaaa
molecular massaaaaaaaaaa
Login to View More

Abstract

Group B Streptococcus polypeptides and polynucleotides encoding them are disclosed. Said polypeptides may be useful for the prophylaxis, diagnostic and / or therapy of streptococcal infection in mammals. Also disclosed are recombinant methods of producing the polypeptide antigens as well as diagnostic assays for detecting streptococcal infections, particularly GBS.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application is a continuation of U.S. patent application Ser. No. 10 / 398,570, now allowed, which has a filing date of Sep. 26, 2003, and which is a national stage application filed under 35 U.S.C. §371 of International Patent Application PCT / CA01 / 01465, accorded an international filing date of Oct. 15, 2001, which claims the benefit U.S. Provisional Application No. 60 / 239,919 filed Oct. 13, 2000, all of which applications are incorporated herein by reference in their entireties.STATEMENT REGARDING SEQUENCE LISTING[0002]The Sequence Listing associated with this application is provided in text format in lieu of a paper copy, and is hereby incorporated by reference into the specification. The name of the text file containing the Sequence Listing is 484112—421C1_SEQUENCE_LISTING.txt. The text file is 29 KB, was created on Jan. 22, 2008, and is being submitted electronically via EFS-Web, concurrent with the filing of the specification.FIE...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(United States)
IPC IPC(8): A61K38/00C12N15/11C12N15/00C12N1/20A61P43/00G01N33/569C12P21/04C07K14/00A61K39/00C12N15/09A61P31/04C07K14/315C07K19/00C12N1/15C12N1/19C12N1/21C12N5/10C12N15/31C12P21/02
CPCA61K39/00Y10S435/975C07K2319/00C07K14/315A61P31/04A61P43/00
InventorMARTIN, DENISRIOUX, STEPHANEBOYER, MARTINEHAMEL, JOSEEBRODEUR, BERNARD R.
OwnerID BIOMEDICAL